http://healthaffairs.org/blog/2008/04/23/from-fda-a-good-framework-for-distributing-information-on-off-label-uses/?utm_source=rss&utm_medium=rss&utm_campaign=from-fda-a-good-framework-for-distributing-information-on-off-label-uses The Policy Journal of the Health Sphere Thu, 24 May 2012 07:58:29 +0000 hourly 1 http://healthaffairs.org/blog/2008/04/23/from-fda-a-good-framework-for-distributing-information-on-off-label-uses/comment-page-1/#comment-17954 Friday Blog Roundup « The Pump Handle Fri, 25 Apr 2008 20:51:33 +0000 http://healthaffairs.org/blog/2008/04/23/from-fda-a-good-framework-for-distributing-information-on-off-label-uses/#comment-17954 [...] Health Affairs Blog has posts by Scott Gottlieb (a former FDA official now at the American Enterprise Institute) and Jerome Kassirer (a former [...] [...] Health Affairs Blog has posts by Scott Gottlieb (a former FDA official now at the American Enterprise Institute) and Jerome Kassirer (a former [...]

]]> http://healthaffairs.org/blog/2008/04/23/from-fda-a-good-framework-for-distributing-information-on-off-label-uses/comment-page-1/#comment-17944 Health Blog : FDA's Off-Label Promotion Notion: 'Good Framework' v. 'Fantasy' Fri, 25 Apr 2008 14:44:08 +0000 http://healthaffairs.org/blog/2008/04/23/from-fda-a-good-framework-for-distributing-information-on-off-label-uses/#comment-17944 [...] on the Health Affairs blog, Gottlieb, now at the American Enterprise Institute, sounds off in support of off-label promotion, citing a delay in the adoption of Genentech’s cancer drug Herceptin to treat breast cancer [...] [...] on the Health Affairs blog, Gottlieb, now at the American Enterprise Institute, sounds off in support of off-label promotion, citing a delay in the adoption of Genentech’s cancer drug Herceptin to treat breast cancer [...]

]]>